InvestorsHub Logo
Followers 66
Posts 1631
Boards Moderated 0
Alias Born 01/31/2014

Re: None

Friday, 08/26/2016 8:25:12 PM

Friday, August 26, 2016 8:25:12 PM

Post# of 721768
Additional thoughts to what others have made, specifically on adding to an existing position of NWBO given the latest warrant exercise / issuance financing.

- on assessing dilution hit, compare actual % dilution to actual drop in price (eg <2% dilution vs ~20% price drop)
- on assessing if this purchase via warrant exercise validates a true value (generally this applies when there is a New investor (not warrant), large $ amount, sophisticated long term investor engaged in due diligence, eg Woodford)
- individual's own diversification and risk profile (each to their own)
- one's existing investment's loss position in NWBO (technically irrelevant, but is important for following ones own investment discipline)
- assessing price to market cap, i.e. valuation (part subjective based on interpretation of due diligence, and part objective based on due diligence, i.e. comparables of other bio techs awaiting phase 3 results.)
- on seeing the forest from the trees (Maverick has some good advice)

Actually more important than deciding whether or not to to buy more shares now (complex for each individual) is to not sell too early.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News